Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185,082 | 85,650 | 153,880 | 118,710 | 340,396 |
| Marketable Securities | 410,269 | 456,933 | 422,623 | 467,590 | 270,331 |
| Other current assets | 15,956 | 12,904 | 18,031 | 10,847 | 12,215 |
| TOTAL | $611,307 | $555,487 | $594,534 | $597,147 | $622,942 |
| Non-Current Assets | |||||
| PPE Net | 13,602 | 12,736 | 11,816 | 11,356 | 9,374 |
| TOTAL | $13,602 | $12,736 | $11,816 | $11,356 | $9,374 |
| Total Assets | $628,555 | $573,163 | $610,784 | $613,976 | $638,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $80,680 | $48,716 | $45,244 | $48,085 | $51,908 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $127,791 | $55,695 | $51,606 | $55,061 | $60,725 |
| Shareholders' Equity | |||||
| Retained earnings | -570,764 | -510,321 | -457,963 | -410,938 | -358,544 |
| Other shareholders' equity | 1,071,528 | 1,027,789 | 1,017,141 | 969,853 | 936,619 |
| TOTAL | $500,764 | $517,468 | $559,178 | $558,915 | $578,075 |
| Total Liabilities And Equity | $628,555 | $573,163 | $610,784 | $613,976 | $638,800 |